Journals

• Campbell, B., Mitchell, P., Yan, B., Parsons, M., Christensen, S., Churilov, L., Dowling, R., Brooks, M., Miteff, F., Levi, C., Krause, M., et al (2014). A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological De�?cits with Intra-Arterial therapy (EXTEND-IA). International Journal of Stroke, 9(1), 126-132. [More Information]
• Adam, R., Priglinger, M., Harrington, T., Gottlieb, D., Krause, M. (2014). An Unusual Cause of Cerebellar Hemorrhage in a Young Patient: Essential Thrombocythemia. Journal of Stroke and Cerebrovascular Diseases, 23(5), e373-e374. [More Information]
• Phu, A., Xu, Z., Brakoulias, B., Mahant, N., Fung, V., De Moore, G., Martin, A., Starcevic, V., Krause, M. (2014). Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients. Journal of Clinical Neuroscience, 21(1), 63-66. [More Information]
• Ma, C., Evans, K., Bertmar, C., Krause, M. (2014). Predictive value of the Royal Melbourne Hospital Falls Risk Assessment Tool (RMH FRAT) for post-stroke patients. Journal of Clinical Neuroscience, 21(4), 607-611.
• Griffiths, D., Newey, A., Faulder, K., Steinfort, B., Krause, M. (2013). Thrombosis of a Developmental Venous Anomaly Causing Venous Infarction and Pontine Hemorrhage. Journal of Stroke and Cerebrovascular Diseases, 22(8), e653-655. [More Information]
• Ma, H., Parsons, M., Christensen, S., Campbell, B., Churilov, L., Connelly, A., Yan, B., Bladin, C., Phan, T., Barber, A., Krause, M., et al (2012). A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). International Journal of Stroke, 7(1), 74-80. [More Information]
• Krause, M., Mahant, N., Kotschet, K., Fung, V., Vagg, D., Wong, C., Morris, J. (2012). Dysexecutive behaviour following deep brain lesions - A different type of disconnection syndrome? Cortex, 48(1), 97-119. [More Information]
• Volkmann, J., Wolters, A., Kupsch, A., Muller, J., Kuhn, A., Schneider, G., Poewe, W., Hering, S., Eisner, W., Muller, J., Krause, M., et al (2012). Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurology, 11(12), 1029-1038. [More Information]
• Sandercock, P., Wardlaw, J., Lindley, R., Dennis, M., Cohen, G., Murray, G., Innes, K., Venables, G., Czlonkowska, A., Kobayashi, A., et al (2012). The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. The Lancet, 379(9834), 2352-2363. [More Information]
• Sandercock, P., Lindley, R., Wardlaw, J., Dennis, M., Innes, K., Cohen, G., Whiteley, W., Perry, D., Soosay, V., Buchanan, D., et al (2011). Update on the third international stroke trial (IST- 3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. Trials, 12(252), 1-9. [More Information]
• Daniels, C., Krack, P., Volkmann, J., Pinsker, M., Krause, M., Tronnier, V., Kloss, M., Schnitzler, A., Wojtecki, L., Bötzel, K., et al (2010). Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease. Movement Disorders, 25(11), 1583-1589. [More Information]
• Witt, K., Daniels, C., Reiff, J., Krack, P., Volkmann, J., Pinsker, M., Krause, M., Tronnier, V., Schnitzler, A., Hilker, R., et al (2008). Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurology, 7(7), 605-614. [More Information]
• Mueller, J., Skogseid, I., Benecke, R., Volkmann, J., Kupsch, A., Trottenberg, T., Poewe, W., Schnitzler, A., Krause, M., Brentrup, A., et al (2008). Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: Results from a prospective, randomized sham-controlled trial. Movement Disorders, 23(1), 131-134. [More Information]
• Szabo, K., Hirsch, J., Krause, M., Ende, G., Henn, F., Sartorius, A., Gass, A. (2007). Diffusion weighted MRI in the early phase after electroconvulsive therapy. Neurological research, 29(3), 256-259. [More Information]
• Henninger, N., Wang, Q., Okun, J., Schwab, S., Krause, M. (2007). Nitrous oxide promotes hyperhomocysteinemia in levodopa treated rats. Parkinsonism and Related Disorders, 13(8), 524-527. [More Information]
• Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschländer, A., Dillmann, U., Krause, M., et al (2006). A randomized trial of deep-brain stimulation for Parkinson's disease. New England Journal of Medicine, 355(9), 896-908. [More Information]
• Lubik, S., Fogel, W., Tronnier, V., Krause, M., König, J., Jost, W. (2006). Gait analysis in patients with advanced Parkinson disease: different or additive effects on gait induced by levodopa and chronic STN stimulation. Journal of Neural Transmission, 113(2), 163-173. [More Information]
• Krause, M., Fogel, W., Tronnier, V., Pohle, S., Hörtnagel, K., Thyen, U., Volkmann, J. (2006). Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration. Movement Disorders, 21(12), 2255-2257. [More Information]
• Kupsch, A., Benecke, R., Müller, J., Trottenberg, T., Schneider, G., Poewe, W., Eisner, W., Wolters, A., Krause, M., et al (2006). Pallidal deep-brain stimulation in primary generalized or segmental dystonia. New England Journal of Medicine, 355(19), 1978-1990. [More Information]
• Krause, M., Fogel, W., Mayer, P., Kloss, M., Tronnier, V. (2004). Chronic inhibition of the subthalamic nucleus in Parkinson's disease. Journal of the Neurological Sciences, 219(1-2), 119-124. [More Information]
• Schroeder, U., Kuehler, A., Hennenlotter, A., Haslinger, B., Tronnier, V., Krause, M., Pfister, R., Sprengelmeyer, R., Lange, K., Ceballos-Baumann, A. (2004). Facial expression recognition and subthalamic nucleus stimulation. Journal of Neurology, Neurosurgery and Psychiatry, 75(4), 648-650.
• Krause, M., Fogel, W., Kloss, M., Rasche, D., Volkmann, J., Tronnier, V. (2004). Pallidal stimulation for dystonia. Neurosurgery, 55(6), 1361-1368.
• Veltkamp, R., Krause, M., Schranz, C., Meinck, H. (2003). Progressive arm weakness and tonic hand spasm from multifocal motor neuropathy in the brachial plexus. Muscle and Nerve, 28(2), 242-245. [More Information]
• Schroeder, U., Kuehler, A., Lange, K., Haslinger, B., Tronnier, V., Krause, M., Pfister, R., Boecker, H., Ceballos-Baumann, A. (2003). Subthalamic nucleus stimulation affects a frontotemporal network: a PET study. Annals of Neurology, 54(4), 445-450. [More Information]

2014

• Campbell, B., Mitchell, P., Yan, B., Parsons, M., Christensen, S., Churilov, L., Dowling, R., Brooks, M., Miteff, F., Levi, C., Krause, M., et al (2014). A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological De�?cits with Intra-Arterial therapy (EXTEND-IA). International Journal of Stroke, 9(1), 126-132. [More Information]
• Adam, R., Priglinger, M., Harrington, T., Gottlieb, D., Krause, M. (2014). An Unusual Cause of Cerebellar Hemorrhage in a Young Patient: Essential Thrombocythemia. Journal of Stroke and Cerebrovascular Diseases, 23(5), e373-e374. [More Information]
• Phu, A., Xu, Z., Brakoulias, B., Mahant, N., Fung, V., De Moore, G., Martin, A., Starcevic, V., Krause, M. (2014). Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients. Journal of Clinical Neuroscience, 21(1), 63-66. [More Information]
• Ma, C., Evans, K., Bertmar, C., Krause, M. (2014). Predictive value of the Royal Melbourne Hospital Falls Risk Assessment Tool (RMH FRAT) for post-stroke patients. Journal of Clinical Neuroscience, 21(4), 607-611.

2013

• Griffiths, D., Newey, A., Faulder, K., Steinfort, B., Krause, M. (2013). Thrombosis of a Developmental Venous Anomaly Causing Venous Infarction and Pontine Hemorrhage. Journal of Stroke and Cerebrovascular Diseases, 22(8), e653-655. [More Information]

2012

• Ma, H., Parsons, M., Christensen, S., Campbell, B., Churilov, L., Connelly, A., Yan, B., Bladin, C., Phan, T., Barber, A., Krause, M., et al (2012). A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). International Journal of Stroke, 7(1), 74-80. [More Information]
• Krause, M., Mahant, N., Kotschet, K., Fung, V., Vagg, D., Wong, C., Morris, J. (2012). Dysexecutive behaviour following deep brain lesions - A different type of disconnection syndrome? Cortex, 48(1), 97-119. [More Information]
• Volkmann, J., Wolters, A., Kupsch, A., Muller, J., Kuhn, A., Schneider, G., Poewe, W., Hering, S., Eisner, W., Muller, J., Krause, M., et al (2012). Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurology, 11(12), 1029-1038. [More Information]
• Sandercock, P., Wardlaw, J., Lindley, R., Dennis, M., Cohen, G., Murray, G., Innes, K., Venables, G., Czlonkowska, A., Kobayashi, A., et al (2012). The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. The Lancet, 379(9834), 2352-2363. [More Information]

2011

• Sandercock, P., Lindley, R., Wardlaw, J., Dennis, M., Innes, K., Cohen, G., Whiteley, W., Perry, D., Soosay, V., Buchanan, D., et al (2011). Update on the third international stroke trial (IST- 3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. Trials, 12(252), 1-9. [More Information]

2010

• Daniels, C., Krack, P., Volkmann, J., Pinsker, M., Krause, M., Tronnier, V., Kloss, M., Schnitzler, A., Wojtecki, L., Bötzel, K., et al (2010). Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease. Movement Disorders, 25(11), 1583-1589. [More Information]

2008

• Witt, K., Daniels, C., Reiff, J., Krack, P., Volkmann, J., Pinsker, M., Krause, M., Tronnier, V., Schnitzler, A., Hilker, R., et al (2008). Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurology, 7(7), 605-614. [More Information]
• Mueller, J., Skogseid, I., Benecke, R., Volkmann, J., Kupsch, A., Trottenberg, T., Poewe, W., Schnitzler, A., Krause, M., Brentrup, A., et al (2008). Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: Results from a prospective, randomized sham-controlled trial. Movement Disorders, 23(1), 131-134. [More Information]

2007

• Szabo, K., Hirsch, J., Krause, M., Ende, G., Henn, F., Sartorius, A., Gass, A. (2007). Diffusion weighted MRI in the early phase after electroconvulsive therapy. Neurological research, 29(3), 256-259. [More Information]
• Henninger, N., Wang, Q., Okun, J., Schwab, S., Krause, M. (2007). Nitrous oxide promotes hyperhomocysteinemia in levodopa treated rats. Parkinsonism and Related Disorders, 13(8), 524-527. [More Information]

2006

• Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschländer, A., Dillmann, U., Krause, M., et al (2006). A randomized trial of deep-brain stimulation for Parkinson's disease. New England Journal of Medicine, 355(9), 896-908. [More Information]
• Lubik, S., Fogel, W., Tronnier, V., Krause, M., König, J., Jost, W. (2006). Gait analysis in patients with advanced Parkinson disease: different or additive effects on gait induced by levodopa and chronic STN stimulation. Journal of Neural Transmission, 113(2), 163-173. [More Information]
• Krause, M., Fogel, W., Tronnier, V., Pohle, S., Hörtnagel, K., Thyen, U., Volkmann, J. (2006). Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration. Movement Disorders, 21(12), 2255-2257. [More Information]
• Kupsch, A., Benecke, R., Müller, J., Trottenberg, T., Schneider, G., Poewe, W., Eisner, W., Wolters, A., Krause, M., et al (2006). Pallidal deep-brain stimulation in primary generalized or segmental dystonia. New England Journal of Medicine, 355(19), 1978-1990. [More Information]

2004

• Krause, M., Fogel, W., Mayer, P., Kloss, M., Tronnier, V. (2004). Chronic inhibition of the subthalamic nucleus in Parkinson's disease. Journal of the Neurological Sciences, 219(1-2), 119-124. [More Information]
• Schroeder, U., Kuehler, A., Hennenlotter, A., Haslinger, B., Tronnier, V., Krause, M., Pfister, R., Sprengelmeyer, R., Lange, K., Ceballos-Baumann, A. (2004). Facial expression recognition and subthalamic nucleus stimulation. Journal of Neurology, Neurosurgery and Psychiatry, 75(4), 648-650.
• Krause, M., Fogel, W., Kloss, M., Rasche, D., Volkmann, J., Tronnier, V. (2004). Pallidal stimulation for dystonia. Neurosurgery, 55(6), 1361-1368.

2003

• Veltkamp, R., Krause, M., Schranz, C., Meinck, H. (2003). Progressive arm weakness and tonic hand spasm from multifocal motor neuropathy in the brachial plexus. Muscle and Nerve, 28(2), 242-245. [More Information]
• Schroeder, U., Kuehler, A., Lange, K., Haslinger, B., Tronnier, V., Krause, M., Pfister, R., Boecker, H., Ceballos-Baumann, A. (2003). Subthalamic nucleus stimulation affects a frontotemporal network: a PET study. Annals of Neurology, 54(4), 445-450. [More Information]